She has been on the floor for three nights. She came in through the emergency room with a hemoglobin in the sevens — that is severely anemic — and a history of heavy menstrual bleeding that had escalated, over six weeks, from heavier-than-usual to soaking-through-pads-every-hour. We transfused two units of blood. We ran her on intravenous estrogen for thirty-six hours. The bleeding slowed. The hemoglobin stabilized. We added tranexamic acid by mouth. This morning's exam showed clots in the vault but no active bleeding. The surgical backup — a D&C with a Foley balloon for tamponade — stayed on the OR's add-on list for two days. We did not need it.
She is being discharged this afternoon. Her partner is coming to pick her up. She is asking, reasonably, how she keeps this from happening again.
The plan is the standard plan. It is the plan every OB/GYN in the country would write: a combined oral contraceptive at a tapering dose for three weeks, with a planned withdrawal bleed afterward, and a follow-up appointment in two weeks for a hemoglobin check. The medication is generic. The cost is ten to twenty dollars without insurance. The clinical indication — heavy menstrual bleeding suppression after an acute episode — is documented in the chart, in the discharge summary, and in the prescription itself.
This should be unremarkable. In 2026, it is not always unremarkable.
Here is what I do now at discharge that I did not do three years ago. I ask the patient for the name of her pharmacy. And I call ahead.
I call the chain pharmacy closest to her home. I ask whether the medication is in stock. I ask whether the chain has a counseling requirement on this formulation in this state that will produce a delay. I ask whether, when my patient walks in this afternoon with a valid prescription from her admitting physician, she will leave with her medication today.
This phone call adds four to twelve minutes to every discharge. It is not in the workflow. There is no billing code for it. It is not taught in residency. It is what I do because the system, in 2026, presumes a pharmacy backstop that does not reliably exist.
Today, the pharmacist on the line tells me the medication is in stock. No counseling delay on this formulation in this state. The patient can come in this afternoon and receive the medication. I write the prescription. I send it electronically. I tell the patient what the pharmacist told me. She nods. She and her partner leave.
That is what happened today. That is not what happens every time.
Two weeks ago, different patient, different chain, different state. Same clinical scenario — acute menorrhagia, inpatient stabilization, discharge with a hormonal taper. I made the call. The pharmacist told me the formulation was in stock but flagged for a counseling hold. Twenty-four-hour hold. My patient would need to come in, speak with the pharmacist, and then return the following day to pick up the medication.
A twenty-four-hour hold on a hormonal taper for a patient who had just spent three nights in the hospital for hemorrhagic anemia. A patient whose hemoglobin was barely stable. A patient for whom the entire point of the prescription is that she starts taking it today, not tomorrow, not after a counseling session with someone who was not part of her clinical care.
I called the pharmacy manager. I explained the clinical situation. The manager told me the hold was corporate policy — not specific to this patient, not based on a clinical concern about this medication, but a blanket policy applied to hormonal prescriptions in that state at that chain. The manager could not override it.
I called a second pharmacy. They had it. No hold. Different chain, twelve miles away. I rewrote the prescription, sent it to the second pharmacy, and called the patient's partner to redirect them.
That is the workaround. That is what clinicians do in 2026 when the last mile of care breaks down. We make phone calls. We comparison-shop pharmacies for our patients from the nursing station. We identify which chains in which states have which policies on which medications. None of this is medicine. All of it is necessary.
I want to be clear about what is happening here. The clinical care — the exam, the diagnosis, the admission, the transfusion, the monitoring, the treatment decision, the discharge plan — all of that worked. The medicine worked. The system that carries the medicine to the patient is what broke.
The prescription I write at discharge is not, in the operational sense, a prescription anymore. It is a request. Whether the request is honored depends on which chain pharmacy the patient uses, which state she lives in, which pharmacist is working that shift, and whether the chain's legal counsel has decided that the dispensing carries acceptable risk. None of those variables are clinical. None of them are about the patient. All of them determine whether she gets the medication that prevents her next emergency-room visit.
The phone call is the workaround. The workaround is what clinicians do when the system stops doing the thing the system was built to do.
When she left today, she had the name of the pharmacy, the phone number, the confirmation that the medication was in stock. She had the prescription, the follow-up appointment, the discharge instructions. She had everything the system is supposed to give her.
What she did not have — what none of my patients have anymore — is the certainty that this would have worked without the phone call. The certainty that the prescription her doctor wrote would have been filled without me calling ahead to negotiate it. That used to be the default. It is now something I have to build, patient by patient, discharge by discharge, one phone call at a time.